Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug‐resistant epilepsy enrolled in a Russian VNS Registry

Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug‐resistant epilepsy enrolled in a Russian VNS Registry

Abstract Introduction Following approval in 2009 of vagus nerve stimulation (VNS Therapy) for drug‐resistant epilepsy (DRE) in the Russian Federation, this is the first multicenter study across Russia to evaluate the safety and efficacy of adjunctive VNS Therapy. Methods The retrospective, observati...

Full description

Bibliographic Details
Main Authors: Anna A. Feygina, Yana N. Koshelyaevskaya, Maxine Dibué, Kira V. Voronkova, Mikhail N. Klochkov, Nadezhda Y. Koroleva, Stanislav S. Ivanov, Ekaterina S. Bolshakova, Elza F. Fatykhova
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Brain and Behavior
Subjects:
drug‐resistant epilepsy
pediatric patients
Russia
seizure frequency
vagus nerve stimulation
VNS Therapy
Online Access:https://doi.org/10.1002/brb3.3076

Internet

https://doi.org/10.1002/brb3.3076

Similar Items